Rice Hall James & Associates LLC acquired a new position in CompoSecure, Inc. (NASDAQ:CMPO - Free Report) in the 3rd quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The fund acquired 268,610 shares of the company's stock, valued at approximately $3,766,000. Rice Hall James & Associates LLC owned 0.33% of CompoSecure at the end of the most recent reporting period.
A number of other hedge funds also recently bought and sold shares of CMPO. Pacific Ridge Capital Partners LLC boosted its stake in shares of CompoSecure by 146.9% during the 2nd quarter. Pacific Ridge Capital Partners LLC now owns 486,462 shares of the company's stock worth $3,308,000 after acquiring an additional 289,451 shares during the last quarter. Boston Partners grew its holdings in CompoSecure by 40.8% during the first quarter. Boston Partners now owns 557,136 shares of the company's stock valued at $4,028,000 after purchasing an additional 161,333 shares during the period. Renaissance Technologies LLC increased its position in CompoSecure by 165.4% in the second quarter. Renaissance Technologies LLC now owns 209,389 shares of the company's stock worth $1,424,000 after buying an additional 130,489 shares in the last quarter. GSA Capital Partners LLP raised its stake in shares of CompoSecure by 87.9% in the first quarter. GSA Capital Partners LLP now owns 103,875 shares of the company's stock worth $751,000 after buying an additional 48,586 shares during the period. Finally, Bailard Inc. bought a new position in shares of CompoSecure in the second quarter worth about $259,000. Hedge funds and other institutional investors own 37.56% of the company's stock.
In other CompoSecure news, insider Adam Joseph Lowe sold 45,000 shares of CompoSecure stock in a transaction on Wednesday, August 14th. The shares were sold at an average price of $11.06, for a total value of $497,700.00. Following the completion of the transaction, the insider now directly owns 1,292,219 shares of the company's stock, valued at $14,291,942.14. This trade represents a 0.00 % decrease in their position. The sale was disclosed in a filing with the SEC, which is available at this link. In other news, insider Adam Joseph Lowe sold 45,000 shares of the business's stock in a transaction that occurred on Wednesday, August 14th. The stock was sold at an average price of $11.06, for a total transaction of $497,700.00. Following the transaction, the insider now owns 1,292,219 shares of the company's stock, valued at approximately $14,291,942.14. The trade was a 0.00 % decrease in their position. The transaction was disclosed in a document filed with the SEC, which can be accessed through the SEC website. Also, CEO Jonathan Wilk sold 618,014 shares of the stock in a transaction on Tuesday, September 17th. The shares were sold at an average price of $7.55, for a total value of $4,666,005.70. Following the sale, the chief executive officer now owns 618,013 shares in the company, valued at $4,665,998.15. The trade was a 0.00 % decrease in their position. The disclosure for this sale can be found here. Over the last 90 days, insiders have sold 10,867,586 shares of company stock worth $82,870,442. Insiders own 74.99% of the company's stock.
Shares of CMPO stock opened at $14.95 on Friday. The company's fifty day simple moving average is $13.55 and its two-hundred day simple moving average is $9.59. CompoSecure, Inc. has a 52 week low of $4.61 and a 52 week high of $15.76. The stock has a market cap of $1.23 billion, a P/E ratio of 14.95, a PEG ratio of 1.11 and a beta of 0.78.
CompoSecure (NASDAQ:CMPO - Get Free Report) last posted its earnings results on Wednesday, August 7th. The company reported $0.27 EPS for the quarter, topping analysts' consensus estimates of $0.26 by $0.01. CompoSecure had a negative return on equity of 11.78% and a net margin of 6.33%. The company had revenue of $108.57 million for the quarter, compared to the consensus estimate of $102.22 million. During the same period in the previous year, the business earned $0.25 earnings per share. On average, analysts anticipate that CompoSecure, Inc. will post 1.1 EPS for the current fiscal year.
Several equities research analysts recently issued reports on the stock. Compass Point increased their target price on shares of CompoSecure from $11.50 to $14.50 and gave the stock a "buy" rating in a report on Tuesday, August 20th. Lake Street Capital increased their price objective on shares of CompoSecure from $14.00 to $18.00 and gave the stock a "buy" rating in a research note on Wednesday, October 2nd. Bank of America lifted their target price on shares of CompoSecure from $9.00 to $10.00 and gave the company a "buy" rating in a research note on Thursday, August 8th. Needham & Company LLC increased their price target on CompoSecure from $15.00 to $16.00 and gave the stock a "buy" rating in a research note on Thursday, August 8th. Finally, JPMorgan Chase & Co. raised their price target on CompoSecure from $8.00 to $12.00 and gave the company a "neutral" rating in a report on Tuesday, August 20th. One investment analyst has rated the stock with a hold rating and six have issued a buy rating to the stock. According to MarketBeat.com, the company currently has a consensus rating of "Moderate Buy" and an average price target of $15.07.
Read Our Latest Stock Analysis on CompoSecure
CompoSecure, Inc manufactures and designs metal, composite, and proprietary financial transaction cards in the United States and internationally. Its primary metal form factors include embedded, metal veneer lite, metal veneer, and full metal products. The company also offers Arculus Cold Storage Wallet, a three-factor authentication solution, which supports specific digital assets, including Bitcoin, Ethereum, non-fungible tokens and others.
This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to [email protected].
Before you consider CompoSecure, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and CompoSecure wasn't on the list.
While CompoSecure currently has a "Moderate Buy" rating among analysts, top-rated analysts believe these five stocks are better buys.